米乐m6
米乐m6:About Henlius
米乐m6:Company Profile
米乐m6:Corporate Culture
Honor
米乐m6:Board of Directors
米乐m6:Management Team
Advisory Committee
Product
米乐m6:Marketed Products
Products in R&D
Clinical Trial
Science & Technology
米乐m6:R&D Result
米乐m6:Innovation Centre
Technology Platform
Quality Management
Manufacturing
米乐m6:Collaborations
米乐m6:Investor Relations
米乐m6:Information Disclosure
Corporate Governance
米乐m6:Financial Reports
Stock Info
IR Calendar
米乐m6:Investor Presentation
米乐m6:Analyst Coverage
米乐m6:Contact Information
Media
米乐m6:Press Release
米乐m6:Multi-media
米乐m6:Media Reports
Media Enquiry
Careers
米乐m6:Talent Philosophy
Staff Life
米乐m6:Training and Development
米乐m6:Contact Us
米乐m6:Contact Information
Customer Message
Privacy
Legal Statement
米乐m6:Compliance
EN
简体
EN
繁體
Home
About Henlius
Company Profile
Corporate Culture
Honor
米乐m6:Board of Directors
米乐m6:Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
米乐m6:Clinical Trial
米乐m6:Science & Technology
R&D Result
米乐m6:Innovation Centre
米乐m6:Technology Platform
Quality Management
Manufacturing
Collaborations
米乐m6:Investor Relations
Information Disclosure
Listing Documents
米乐m6:Announcement & Circulars
Corporate Governance
米乐m6:Financial Reports
米乐m6:Stock Info
IR Calendar
米乐m6:Investor Presentation
Analyst Coverage
米乐m6:Contact Information
Media
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
米乐m6:Multi-media
Company
Event
米乐m6:Popular Science
米乐m6:Media Reports
Media Enquiry
Careers
Talent Philosophy
米乐m6:Staff Life
米乐m6:Training and Development
Job Opportunities
Contact Us
米乐m6:Contact Information
Customer Message
Privacy
米乐m6:Legal Statement
米乐m6:Compliance
Be the most trusted biotech company
Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
米乐m6:Multi-media
Company
米乐m6:Popular Science
Highlights
Download
Media Reports
米乐m6:Media Enquiry
2021-11-18
Making biologic medicines more accessible
Global biopharmaceutical company Henlius aims to greatly improve patient well-being with affordable and innovative biologic medicines
2020-02-14
Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Generics Bulletin
2019-05-09
An original force in biosimilars
Nature Research
2018-06-27
Growing Antibody Industry in China Sees Major Opportunities
GEN Exclusives
2018-05-10
China's global investment push opens doors for domestic biotechs
BIOPHARMA DIVE
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
米乐m6在线登录 - 官方下载 - 米乐m6平台
米乐m6登录-手机app下载
米乐M6APP官网登录|米乐m6
55世纪 - 55世纪app - 官网登录
55世纪 - 官网